Cargando…

Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2

Mucosal immunity plays a significant role in host defense against viruses in the respiratory tract. Because the upper respiratory airway is a primary site of SARS-CoV-2 entry, immunization at the mucosa via the intranasal route could potentially lead to induction of local sterilizing immunity that p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jearanaiwitayakul, Tuksin, Seesen, Mathurin, Chawengkirttikul, Runglawan, Limthongkul, Jitra, Apichirapokey, Suttikarn, Sapsutthipas, Sompong, Phumiamorn, Supaporn, Sunintaboon, Panya, Ubol, Sukathida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310126/ https://www.ncbi.nlm.nih.gov/pubmed/34358183 http://dx.doi.org/10.3390/vaccines9070768

Ejemplares similares

The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2022)

Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2021)

The Adjuvant Activity of BCG Cell Wall Cytoskeleton on a Dengue Virus-2 Subunit Vaccine
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2023)

Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination
por: Nantachit, Nattika, et al.
Publicado: (2016)

Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study
por: Rungrojcharoenkit, Kamonthip, et al.
Publicado: (2020)

Immunogenic Properties of a BCG Adjuvanted Chitosan Nanoparticle-Based Dengue Vaccine in Human Dendritic Cells
por: Hunsawong, Taweewun, et al.
Publicado: (2015)

CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2
por: Laotee, Sedthawut, et al.
Publicado: (2023)

Comparison of safety and immunogenicity of CoronaVac and ChAdOx1 against the SARS-CoV-2 circulating variants of concern (Alpha, Delta, Beta) in Thai healthcare workers
por: Angkasekwinai, Nasikarn, et al.
Publicado: (2022)

Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population
por: Intapiboon, Porntip, et al.
Publicado: (2021)

Novel Potent Autophagy Inhibitor Ka-003 Inhibits Dengue Virus Replication
por: Limthongkul, Jitra, et al.
Publicado: (2023)

Immunodiagnosis of Fasciola gigantica Infection Using Monoclonal Antibody-Based Sandwich ELISA and Immunochromatographic Assay for Detection of Circulating Cathepsin L1 Protease
por: Anuracpreeda, Panat, et al.
Publicado: (2016)

Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
por: Pinpathomrat, Nawamin, et al.
Publicado: (2022)

Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
por: Pinpathomrat, Nawamin, et al.
Publicado: (2022)

Subversion of Innate Defenses by the Interplay between DENV and Pre-Existing Enhancing Antibodies: TLRs Signaling Collapse
por: Modhiran, Naphak, et al.
Publicado: (2010)

Synergistic Reinforcement of Cellulose Microfibers from Pineapple Leaf and Ionic Cross-Linking on the Properties of Hydrogels
por: Sriraveeroj, Nithinan, et al.
Publicado: (2022)

Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2
por: Li, Letian, et al.
Publicado: (2021)

Molecular detection and genetic diversity of Leucocytozoon sabrazesi in chickens in Thailand
por: Chawengkirttikul, Runglawan, et al.
Publicado: (2021)

Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates
por: Siriwattananon, Konlavat, et al.
Publicado: (2021)

Chikungunya Virus Infection of Cell Lines: Analysis of the East, Central and South African Lineage
por: Wikan, Nitwara, et al.
Publicado: (2012)

The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine
por: Mahasirimongkol, Surakameth, et al.
Publicado: (2022)

Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses
por: Kawai, Atsushi, et al.
Publicado: (2023)

Molecular genetic diversity and bioinformatic analysis of Leucocytozoon sabrazesi based on the mitochondrial genes cytb, coxI and coxIII and co-infection of Plasmodium spp.
por: Nooroong, Pornpiroon, et al.
Publicado: (2022)

Molecular characterization and genetic diversity of Babesia bovis and Babesia bigemina of cattle in Thailand
por: Srionrod, Nitipon, et al.
Publicado: (2022)

Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
por: Halstead, Scott B, et al.
Publicado: (2010)

Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
por: Nelson, Sean A., et al.
Publicado: (2021)

Intra-host diversities of the receptor-binding domain of stork faeces-derived avian H5N1 viruses and its significance as predicted by molecular dynamic simulation
por: Ubol, Sukathida, et al.
Publicado: (2011)

Full length and protease domain activity of chikungunya virus nsP2 differ from other alphavirus nsP2 proteases in recognition of small peptide substrates
por: Saisawang, Chonticha, et al.
Publicado: (2015)

Chikungunya nsP2 protease is not a papain-like cysteine protease and the catalytic dyad cysteine is interchangeable with a proximal serine
por: Saisawang, Chonticha, et al.
Publicado: (2015)

Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse
por: Du, Yingying, et al.
Publicado: (2021)

Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model
por: Patel, DR, et al.
Publicado: (2022)

Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers
por: Imsuwansri, Thanarath, et al.
Publicado: (2023)

Effective Equine Immunization Protocol for Production of Potent Poly-specific Antisera against Calloselasma rhodostoma, Cryptelytrops albolabris and Daboia siamensis
por: Sapsutthipas, Sompong, et al.
Publicado: (2015)

Proteomic Analysis of Chikungunya Virus Infected Microgial Cells
por: Abere, Bizunesh, et al.
Publicado: (2012)

Systemic and Mucosal Antibody Responses to Soluble and Nanoparticle-Conjugated Antigens Administered Intranasally
por: Howe, Savannah E., et al.
Publicado: (2016)

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
por: Mao, Tianyang, et al.
Publicado: (2022)

Intranasal administration of regulatory dendritic cells is useful for the induction of nasal mucosal tolerance in a mice model of allergic rhinitis
por: Suzuki, Motohiko, et al.
Publicado: (2020)

Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants
por: Lei, Hong, et al.
Publicado: (2022)

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
por: Hasegawa, Hideki, et al.
Publicado: (2009)

Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines
por: Yoshino, Naoto, et al.
Publicado: (2023)

Third-stage Gnathostoma spinigerum larva excretory secretory antigens modulate function of Fc gamma receptor I-mediated monocytes in peripheral blood mononuclear cell culture
por: Benjathummarak, Surachet, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_me9k4bkcnc0osvrcvolt3fld6l